CYH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03
Fiyat $2.72
Piyasa Değeri (MRQ) $384M
P/E (TTM) 1.5
Hisse Başına Kâr (TTM) $1.86
Gelir (TTM) $11.98B
ROE (TTM) -16.7%
D/E Borç/Özsermaye (MRQ) -6.9
52 Haftlık Aralık $2–$4

CYH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04
aralık
çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Hisse bölünmeleri 1
Ex-tarihi Bölünme Tür
22 Nisan 2016 121-for-100 İleri

Community Health Systems, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗

Wikidata ↗

sektörHealth Care endüstriHealth Care çalışanlar44.000 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06
Gelir$12.48B
2016-12-31 → 2025-12-31
Hisse Başına Kâr$3.77
2016-12-31 → 2025-12-31
Serbest Nakit Akışı$208M
2016-12-31 → 2025-12-31
Net kar marjı2.1%
2018-12-31 → 2025-12-31
Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik 5 Yıllık trend CYH 5Y ort. Akran Ortalaması Sonuç
P/E (TTM) 1.55Y ort. ≈3.4 ≈3.4 15.5 Düşük değerli
F/S (TTM) 0.05Y ort. ≈0.1 ≈0.1 1.2 Düşük değerli
F/D (MRQ) -0.35Y ort. ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.15Y ort. ≈13.1 ≈13.1 10.6 Düşük değerli
Fiyat / Serbest Nakit Akışı (TTM) -2.15Y ort. ≈-0.8 ≈-0.8 · ·
Fiyat / Nakit Akışı (TTM) 3.05Y ort. ≈-1.6 ≈-1.6 6.5 Düşük değerli
EV / Revenue (EV / Gelir) 0.85Y ort. ≈1.0 ≈1.0 · ·
EV / FCF 50.55Y ort. ≈-4.9 ≈-4.9 · ·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

13
Ex-tarihiMiktarPara BirimiTemettü Verimi
Ara 13, 2012$0,21USD≈0.84%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14
Ort. Sürpriz 37.9%
Sonraki Rapor Eki 21, 2026
DönemRaporEPS GerçekEPS TahminSürpriz
30 Haziran 2026 Tem 21, 2026 $-0.19 $-0.06 -201.1%
31 Mart 2026 $-0.48 $-0.10 -387.3%
31 Aralık 2025 $-0.01 $-0.10 90.5%
30 Eylül 2025 $1.27 $-0.25 610.5%
30 Haziran 2025 $-0.05 $-0.11 52.6%
31 Mart 2025 $-0.03 $-0.08 62.6%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15
Gelir Tablosu 13
Metrik Eğilim 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
Bilanço 26
Metrik Eğilim 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
Nakit Akışı 13
Metrik Eğilim 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
Kârlılık 7
Metrik Eğilim 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
Likidite ve Solventlik 4
Metrik Eğilim 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
Verimlilik 2
Metrik Eğilim 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
Hisse Başına 5
Metrik Eğilim 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Büyüme Oranları 9
Metrik Eğilim 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
Değerleme (TTM) 13
Metrik Eğilim 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Gelir $12.48B $12.63B $12.49B $12.21B $12.37B
Faaliyet Kâr Marjı % 11.9% 4.3% 7.7% 6.7% 11.3%
Net Gelir $509M $-516M $-133M $46M $230M
Seyreltilmiş Hisse Başı Kâr $3.77 $-3.90 $-1.02 $0.35 $1.76

Kurumsal Sahipler (13F) 197 dosya · $415.1M toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 197
Tutulan Değer $415.1M
Yeni pozisyonlar 31
Çıkan pozisyonlar 24
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar Çıkan pozisyonlar Artırıldı Azaldı Net hisse senedi değişimi
31 (+9 önceki Ç'ye göre) 24 (+4 önceki Ç'ye göre) 69 (+6 önceki Ç'ye göre) 54 (-9 önceki Ç'ye göre) +7.0M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum Değer Hisse senetleri % izlenen 13F'nin Tür
CastleKnight Management LP $44.704.517 13.384.586 10,77% Hisse senetleri
Apollo Management Holdings, L.P. $39.610.817 11.859.526 9,54% Hisse senetleri
BlackRock, Inc. $36.507.995 10.930.538 8,79% Hisse senetleri
VANGUARD GROUP INC $28.605.579 9.168.455 6,89% Hisse senetleri
Eversept Partners, LP $26.267.680 7.864.575 6,33% Hisse senetleri
NOMURA HOLDINGS INC $22.388.384 6.703.109 5,39% Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC $17.668.370 5.289.931 4,26% Hisse senetleri
WHITEBOX ADVISORS LLC $12.467.362 3.732.743 3,00% Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC $10.582.352 3.167.702 2,55% Hisse senetleri
STATE STREET CORP $10.226.622 3.061.863 2,46% Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC $10.082.117 3.018.598 2,43% Hisse senetleri
Saba Capital Management, L.P. $9.626.444 2.882.169 2,32% Hisse senetleri
Owl Creek Asset Management, L.P. $8.452.277 2.530.622 2,04% Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8.176.380 2.448.018 1,97% Hisse senetleri
DIMENSIONAL FUND ADVISORS LP $7.854.253 2.351.460 1,89% Hisse senetleri
D. E. Shaw & Co., Inc. $7.829.388 2.344.128 1,89% Hisse senetleri
AQR CAPITAL MANAGEMENT LLC $7.651.362 2.290.827 1,84% Hisse senetleri
TWO SIGMA INVESTMENTS, LP $7.365.822 2.205.336 1,77% Hisse senetleri
Diameter Capital Partners LP $6.138.793 1.837.962 1,48% Hisse senetleri
BANK OF AMERICA CORP /DE/ $5.903.847 1.767.619 1,42% Hisse senetleri
GOLDMAN SACHS GROUP INC $5.868.073 1.756.908 1,41% Hisse senetleri
TWO SIGMA ADVISERS, LP $5.816.476 1.864.255 1,40% Hisse senetleri
CARRONADE CAPITAL MANAGEMENT, LP $5.230.000 1.565.847 1,26% Hisse senetleri
Allianz Asset Management GmbH $5.167.919 1.547.281 1,24% Hisse senetleri
MORGAN STANLEY $4.800.489 1.437.272 1,16% Hisse senetleri
NORTHERN TRUST CORP $4.681.414 1.401.621 1,13% Hisse senetleri
Silver Rock Financial LP $3.674.000 1.100.000 0,89% Hisse senetleri
CITADEL ADVISORS LLC $3.475.360 1.040.527 0,84% Hisse senetleri
Assenagon Asset Management S.A. $2.788.275 834.813 0,67% Hisse senetleri
VANGUARD FIDUCIARY TRUST CO $2.642.231 791.087 0,64% Hisse senetleri
Jefferies Financial Group Inc. $2.481.286 742.900 0,60% Hisse senetleri
Alta Fundamental Advisers LLC $2.161.411 647.129 0,52% Hisse senetleri
Bank of New York Mellon Corp $2.122.084 635.354 0,51% Hisse senetleri
MARSHALL WACE, LLP $1.906.575 570.831 0,46% Hisse senetleri
MILLENNIUM MANAGEMENT LLC $1.701.580 509.455 0,41% Hisse senetleri
ExodusPoint Capital Management, LP $1.664.603 498.384 0,40% Hisse senetleri
READYSTATE ASSET MANAGEMENT LP $1.657.729 496.326 0,40% Hisse senetleri
WOLVERINE ASSET MANAGEMENT LLC $1.339.674 401.100 0,32% Alım opsiyonu
Helix Partners Management LP $1.336.000 400.000 0,32% Hisse senetleri
Susquehanna Portfolio Strategies, LLC $1.280.940 383.515 0,31% Hisse senetleri
Voleon Capital Management LP $1.247.032 373.363 0,30% Hisse senetleri
Invesco Ltd. $1.076.599 322.335 0,26% Hisse senetleri
TUDOR INVESTMENT CORP ET AL $999.388 299.218 0,24% Hisse senetleri
Pathstone Holdings, LLC $895.621 268.150 0,22% Hisse senetleri
Prescott Group Capital Management, L.L.C. $863.076 258.406 0,21% Hisse senetleri
UBS Group AG $851.089 254.817 0,21% Hisse senetleri
MILLENNIUM MANAGEMENT LLC $835.000 250.000 0,20% Satım opsiyonu
FEDERATED HERMES, INC. $812.599 243.293 0,20% Hisse senetleri
LPL Financial LLC $737.239 220.730 0,18% Hisse senetleri
IEQ CAPITAL, LLC $657.963 196.995 0,16% Hisse senetleri

Tüm 197 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 1 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi Dosyalandı Hisse Durum Amaç Başvuru
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 başvurular 11 Mart 2021 · İlk başvuru · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 56 içeriden öğrenenler · 29 yöneticiler · 23 yönetim kurulu üyeleri

19
İçeriden Öğrenen Rol Son işlem Sahip olunan hisse senetleri Alımlar 12ay Satışlar 12ay Net 12ay
Kevin J Hammons CEO 01 Mart 2026 A 895.545 0 0 $0
Tim Hingtgen CEO 01 Mart 2025 A 1.388.781 0 0 $0
Jason K Johnson EVP & CFO 01 Mart 2026 A 268.439 0 0 $0
Thomas J Aaron EVP and CFO 07 Aralık 2019 F 241.515 0 0 $0
Larry W Cash President and CFO 01 Mart 2017 A 568.152 0 0 $0
Miguel S Benet President and CMO 01 Mart 2025 D 47.635 0 0 $0
Austen D Mason Regional President 01 Mart 2025 A 142.500 0 0 $0
Mark B Medley Regional President 01 Mart 2025 A 128.637 0 0 $0
Chad A Campbell Regional President 01 Mart 2025 A 136.815 0 0 $0
Charles J Cova Regional President 01 Mart 2024 A 58.701 0 0 $0
Lynn T Simon President and CMO 01 Mart 2024 A 482.657 0 0 $0
Beryl Ramsey Division President 01 Mart 2019 A 62.969 0 0 $0
Patton Paul Smith Division President 01 Mart 2019 F 119.017 0 0 $0
Iii John W Mcclellan Division President 01 Mart 2017 A 41.242 0 0 $0
Robert O Horrar Division President 01 Mart 2017 A 68.649 0 0 $0
Martin Bonick Division President 01 Mart 2017 A 100.458 0 0 $0
Michael T Portacci Division President 01 Mart 2017 A 110.156 0 0 $0
Thomas Daniel Miller Division President 01 Mart 2016 A 112.107 0 0 $0
David Lewis Miller President and COO 01 Mart 2016 A 440.840 0 0 $0
William S Hussey Division President 28 Ekim 2015 M 121.568 0 0 $0
Martin Dewayne Smith Division President 03 Haziran 2015 M 94.111 0 0 $0
Gary D Newsome Division President - Group Ops 25 Ağustos 2008 M 118.286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 01 Haziran 2026 A 30.000 0 0 $0
Phillip A. Posey SVP & CAO 01 Mart 2026 A 51.736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 01 Mart 2026 A 287.750 0 0 $0
Kevin A Stockton EVP, Operations & Development 01 Mart 2026 A 208.290 0 0 $0
Rachel A Seifert Executive VP and Secretary 01 Mart 2017 F 243.065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25 Şubat 2012 F 78.379 0 0 $0
Martin G Schweinhart Senior Vice President 01 Mart 2006 A 40.354 0 0 $0
William Norris Jennings Yönetim kurulu üyesi 25 Ağustos 2026 S 38.468 0 1 $-118.400
Ranga K Krishnan Yönetim kurulu üyesi 30 Haziran 2026 M 170.023 0 0 $0
Fawn D Lopez Yönetim kurulu üyesi 01 Mart 2026 A · 0 0 $0
Ronald L Burgess JR Yönetim kurulu üyesi 01 Mart 2026 A · 0 0 $0
Susan W Brooks Yönetim kurulu üyesi 01 Mart 2026 A 108.695 0 0 $0
Hubert James Williams Yönetim kurulu üyesi 01 Mart 2026 A 211.863 0 0 $0
Joseph Arthur Hastings Yönetim kurulu üyesi 01 Mart 2026 A 0 0 0 $0
Elizabeth T Hirsch Yönetim kurulu üyesi 01 Mart 2026 A 162.059 0 0 $0
James S. Ely III Yönetim kurulu üyesi 01 Mart 2026 A 412.876 0 0 $0
John A Fry Yönetim kurulu üyesi 01 Mart 2026 A 268.966 0 0 $0
John A Clerico Yönetim kurulu üyesi 01 Mart 2026 A 368.763 0 0 $0
Michael Dinkins Yönetim kurulu üyesi 01 Mart 2026 A 225.882 0 0 $0
Wayne T Smith Yönetim kurulu üyesi 01 Mart 2026 A 5.217.579 0 0 $0
Julia B North Yönetim kurulu üyesi 01 Mart 2021 A 162.056 0 0 $0
Mitchell H Watson JR Yönetim kurulu üyesi 16 Mayıs 2017 M 22.594 0 0 $0
Harvey Klein MD Yönetim kurulu üyesi 15 Mart 2010 M 10.383 0 0 $0
Dale F Frey Yönetim kurulu üyesi 31 Mart 2008 A 20.000 0 0 $0
Thomas H Lister Yönetim kurulu üyesi 21 Eylül 2004 S 0 0 0 $0
Thodore Forstmann Yönetim kurulu üyesi 21 Eylül 2004 S 0 0 0 $0
Sandra Horbach Yönetim kurulu üyesi 21 Eylül 2004 S 0 0 0 $0
Robert J Dole Yönetim kurulu üyesi 06 Mayıs 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10% sahip 21 Eylül 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10% sahip 21 Eylül 2004 S 0 0 0 $0
Winston Hutchins 10% sahip 21 Eylül 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10% sahip 21 Eylül 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10% sahip 21 Eylül 2004 S 0 0 0 $0
Benjamin C Fordham · 01 Mart 2021 A 254.608 0 0 $0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 25 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon Ağırlık Birimler Tarih itibarıyla Kaynak
BSJR · Invesco Exchange-Traded Self-Indexe… 2,68% 23.297.000 01 Ekim 2026 Günlük
EBIT · Harbor ETF Trust 0,45% 19.210 NS 31 Temmuz 2026 N-PORT
IWC · iShares Trust 0,09% 443.690 SH 11 Eylül 2026 Günlük
IHF · iShares Trust 0,05% 223.947 SH 11 Eylül 2026 Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113.109 SH 19 Ağustos 2026 Günlük
NEAR · iShares U.S. ETF Trust 0,03% 1.340.000 SH 11 Eylül 2026 Günlük
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 226.491 SH 01 Ekim 2026 Günlük
IWM · iShares Trust 0,01% 3.425.206 SH 11 Eylül 2026 Günlük
RSSL · Global X Funds 0,01% 62.038 NS 31 Temmuz 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746.733 SH 19 Ağustos 2026 Günlük
VHT · VANGUARD WORLD FUND 0,01% 349.881 SH 19 Ağustos 2026 Günlük
DFAS · Dimensional ETF Trust 0,01% 289.348 NS 31 Temmuz 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202.789 NS 31 Temmuz 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33.838 NS 31 Temmuz 2026 N-PORT
ITOT · iShares Trust 0,00% 203.848 SH 11 Eylül 2026 Günlük
IWV · iShares Trust 0,00% 42.177 SH 03 Eylül 2026 Günlük
DCOR · Dimensional ETF Trust 0,00% 6.184 NS 31 Temmuz 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31.135 NS 31 Temmuz 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1.347.195 SH 19 Ağustos 2026 Günlük
VTI · VANGUARD INDEX FUNDS 0,00% 3.813.888 SH 19 Ağustos 2026 Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9.817 SH 19 Ağustos 2026 Günlük
DFSU · Dimensional ETF Trust 0,00% 24 NS 31 Temmuz 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15 Temmuz 2026 Günlük
VPLS · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
IWN · iShares Trust · 1.223.127 SH 11 Eylül 2026 Günlük

CYH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21
derecelendirme · 16 analist TUT
Medyan hedef $3.12 +14,9%
1 6,2% Güçlü Al
1 6,2% Al
6 37,5% Tut
7 43,8% Sat
1 6,2% Güçlü Sat

12 Aylık Fiyat Hedefi

8 analist · 2026-10-01

Ortalama hedef $3.16 +16,0%

Şimdi Mevcut fiyat $2.72
Düşük$2.00 Ortalama$3.16 Yüksek$4.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

Son Haberler Bu şirketten bahseden son manşetler

23

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kaynak: SEC 10-Q dosyalandı Tem 23, 2026